Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022-2024)
新型头孢布烯-阿维巴坦、头孢他啶-阿维巴坦及其对照药物对来自美国各地门诊中心和疗养院的肠杆菌科细菌挑战集的活性(2022-2024 年)
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01867-24
Fouad, Aliaa; Bobenchik, April M; Chamberland, Robin; Clark, Andrew E; Huse, Holly K; Martin, Isabella W; Mochon, A Brian; Munson, Erik; Sfeir, Maroun M; Srodon, Monica; Taylor, Kimberly; Wang, Yungchou; Westblade, Lars F; Nicolau, David P; Asempa, Tomefa E